Falco Lombardi
Registered User
Not sure where the negativity and ambivalence is coming from about this deal. It covers only RFA years and guys who put up 25-30 points a year playing almost exclusively in a 4th line role don’t grow on trees. I would have preferred we kept it at or below $2M because of the other RFAs we still need to sign, not because he isn’t worth it.
It comes from analytical viewpoints like this that back up what the eye test told us last year:
He was really not good last year, specifically defensively. Now can that change? Of course it could, but coming off that, I would have expected that we could have kept the AAV down
Last edited: